Objectives. A number of recently published studies have shown that the sympathetic nervous system may infl uence cancer progression. Th ere are, however, some ambiguities about the role of the parasympathetic nerves in the modulation of growth of diff erent tumor types. Moreover, tumor models used for investigation of the autonomic neurotransmission role in the processes related to the cancer growth and progression are mainly of the solid nature. Th e knowledge about the nervous system involvement in the modulation of the development and progression of malignant ascites is only fragmental. Th erefore, the aim of the present article was to summarize the results of our experimental studies focused on the elucidation of the role of the autonomic nervous system in the modulation of tumor growth in animals. We are summarizing data from studies, in which not only diff erent experimental approaches in order to infl uence the autonomic neurotransmission, but also diff erent tumor models have been used.
During the last years, many authors have focused on the elucidation of the role of the nervous system in the regulation of biological pathways involved in the cancer growth and development of metastasis (Mancino et al. 2011; Armaiz-Pena et al. 2013; Magnon et al. 2013) . Th ese studies have greatly expanded our knowledge, especially about the sympathetic nervous system involvement in cancer biology and about the eff ects of locally released sympathetic neurotransmitters, on the cellular immune responses, lymphocyte traffi c, infl ammatory processes and cytokine production, vessel permeability, tumor-associated angiogenesis or tumor cell proliferation, invasion, and survival (Raju et al. 2007; Raju et al. 2009; Sloan et al. 2010; Lackovicova et al. 2011; Cao and During 2012; Lansdown and Rees 2012; . Overall, the obtained data have strongly indicated stimulatory eff ect of the sympathetic nerves on the tumor progression followed by shortened survival. In contrast, only few studies have been focused on the eff ect of parasympathetic nervous system on the processes related to the cancer development and progression. Th e majority of these studies have investigated the eff ect of interruption of signals, conveyed by the vagus nerve, using various types of vagotomy on tumor risk and metastasis formation (Fujita et al. 1979; Tatsuta et al. 1985; Fisher et al. 1994; Lundegardh et al. 1994; Ekbom et al. 1998; Bayon Lara et al. 2001; Erin et al. 2008; Ahsberg et al. 2009 ). However, when comparing the eff ect of the sympathetic nervous system on tumor growth, more unambiguous and confused results have been obtained. Although, Gidron and co-workers (2005) have suggested inhibitory eff ect of the vagus nerve on the tumorigenesis, this eff ect has not yet been clearly demonstrated. Based on the works of Tracey and colleagues (Tracey 2002; Pavlov and Tracey 2005) about an anti-infl ammatory activity of the vagus nerve and studies on the signifi cance of the infl ammatory tumor microenvironment role in the cancer progression (Croci et al. 2007; Oluwadara et al. 2010) , a hypothesis that the vagus nerve might slow the tumorigenesis by suppression of the peripheral proinfl ammatory cytokine levels has been proposed (Gidron et al. 2005) . However, there is also a contrary opinion expressed by Magnon and co-workers (2013) , who, in their pioneering study, have focused on the eff ect of autonomic nerves on the prostate cancer progression. Th ey have found that the formation of autonomic nerve fi bers in the prostate gland may regulate prostate cancer development and dissemination in mouse models (Magnon et al. 2013) . Moreover, authors have proposed an important role of the sympathetic nerves in the initial phases of the cancer development by promoting the tumor cells survival, and cholinergic fi bers of the parasympathetic nervous system in tumor cell invasion, migration, and distant metastasis formation through stromal Chrm1-mediated signals. According to this idea, the sympathetic fi bers accumulate in the normal tissues and infi ltrate the tumor edge, whereas parasympathetic fi bers infi ltrate tumor tissues (Magnon et al. 2013) .
Based on the above-mentioned facts, it can be concluded that there is an ambiguity especially in the role of the parasympathetic branch of the autonomic nervous system in tumor development, growth, and progression. Moreover, majority of the studies investigating interactions between the nervous system and tumors have used solid tumor models (e.g. fi brosarcoma, melanoma, breast cancer, prostate cancer, gastric cancer), in which the tumor progression aff ecting processes, such as angiogenesis, lymphangiogenesis, and neurogenesis, can be initiated by the release of angiogenic and neurotrophic factors from the tumor cells themselves (Entschladen et al. 2006; Palm and Entschladen 2007; Voss and Entschladen 2010) .
More than a decade, our Laboratory of Neurobiology is focusing on the investigation of mechanisms participating in the neural regulation of the tumor growth (neurobiology of cancer). In our experiments, we have used several experimental approaches, including sympathectomy, vagotomy, and stimulation of the vagus nerve or lesions of selected brain structures. Moreover, we have also used tumor models with diff erent features, namely solid rat fi brosarcoma and murine melanoma, and rat ascites hepatoma.
Th e aim of the present article is to summarize the data of our experimental studies focusing on the elucidation of the role of the autonomic nervous system in the modulation of the tumor growth, in which we have used not only diff erent experimental approaches, in order to infl uence the autonomic neurotransmission, but also diff erent tumor models (Table 1) .
Used tumor models
In our experimental studies, we have focused on the investigation of the nervous system eff ect on cancer biology. We have used three diff erent types of tumor models, namely solid rat intra-abdominal fi brosarcoma, solid murine subcutaneous melanoma, and rat ascites hepatoma.
Rat intra-abdominal fi brosarcoma. Rat fi brosarcoma was induced by a single injection of 0.5×10 6 fi brosarcoma cells dispersed in 2 ml of serum-free RPMI 1640 medium. Th e rat BP6-TU2 fi brosarcoma cells used were routinely cultured in RPMI 1640 medium containing 10% fetal calf serum supplemented with antibiotics, namely kanamycin and streptomycin. Tumor cells were injected to the male Wistar rats (AnLab, Prague, Czech Republic) intraperitoneally (into the left bottom quadrant of the abdominal cavity) without anesthesia. Control rats were exposed to the same volume of the serum-free medium.
Murine subcutaneous melanoma. Murine melanoma was induced by a single dose of 3×10 3 tumor cells in 0.1 ml of RPMI 1640 medium per animal without anesthesia. A B16-F10 melanoma cell suspension was injected subcutaneously (into the subcutaneous space at the level of the thoraco-lumbar spinal cord). Before tumor cells inoculation, back of animals was shaven and disinfected. Experiments were performed on 3 months-old male mice (strain C57BL/6J) that were bred at the Institute of Experimental Endocrinology, Slovak Academy of Science. Control mice were injected only with serum-free medium.
Rat ascites hepatoma. Rat ascitic hepatoma was induced using a model of one-off injection of 5×10 6 Yoshida AH-130 ascites hepatoma cells in a total volume of 2 ml of phosphate solution (pH 7.3) per rat without anesthesia. Tumor cell suspension was injected intraperitoneally (into the left bottom quadrant of the abdominal cavity) into syngeneic male Wistar rats (AnLab, Prague, Czech Republic). Animals injected by vehicle without tumor cells served as control.
Interventions and their eff ects on tumor growth
Chemical sympathectomy. Chemical sympathectomy was performed 7 days before the tumor cells application in conscious animals by intraperitoneal injection of 6-hydroxydopamine hydrobromide (6-OHDA; 100 mg/kg of body weight, Sigma-Aldrich, Germany) over 2 consecutive days. Th e 6-OHDA was dissolved in sterile saline containing 0.1% of the antioxidant ascorbic acid (Sigma-Aldrich, Germany). Th is dose has been shown to induce destruction of the sympathetic nerve endings aft er 3-5 days and this eff ect lasted for at least 21 days in spleen (Kruszewska et al. 1995 ). An effi ciency of the sympathectomy was confi rmed immediately aft er application of 6-OHDA by presence of eyelids ptosis in the sympathectomized animals (Claude Bernard-Horner's syndrome) and blood in urine indicating the destruction of the sympathetic nerve endings in the urinary tract. Moreover, 7 days aft er 6-OHDA treatment, we found decreased levels of norepinephrine in the spleen Horvathova et al. 2016a) . Control animals to 6-OHDA groups were intraperitoneally injected with vehicle (sterile saline containing 0.1% of the antioxidant ascorbic acid).
Th e incidence of the intra-abdominal fi brosarcoma in Wistar rats was aft er 6-OHDA-induced sympathectomy signifi cantly reduced. Tumor masses were found in the abdominal cavity of 87% animals with an intact sympathetic nervous system injected with BP6-TU2 tumor cells compared to 61% rats in • decreased tumor incidence • prolonged survival of tumorbearing rats
• no eff ect on tumor incidence • no eff ect on survival of tumor-bearing rats
B16-F10 melanoma (murine)
• delayed development of tumors • no eff ect on tumor incidence • ambiguous eff ect on size of developed tumors • prolonged survival of tumorbearing mice not investigated not investigated
Ascitic tumor
Yoshida AH130 ascites hepatoma (rat)
• no eff ect on tumor incidence • no eff ect on survival of tumorbearing rats
• no eff ect on tumor incidence • no eff ect on survival of tumor-bearing rats the group that received 6-OHDA before injection of BP6-TU2 cells. Moreover, a signifi cantly prolonged survival of sympathectomized tumor-bearing rats in comparison with animals that did not receive 6-OHDA pretreatment was also observed. Median survival of tumor-bearing rats with intact sympathetic nerves was 39.5 days and of tumor-bearing animals treated with 6-OHDA was 55 days (Lackovicova et al. 2011) .
In animals injected subcutaneously with the murine melanoma cells, similar eff ect of sympathectomy on tumor growth and survival was observed, as well. Here, we noticed signifi cantly delayed development of tumors in the sympathectomized mice in comparison with the mice that were not treated with 6-OHDA. Moreover, we have shown that chemical sympathectomy also signifi cantly prolonged the mice survival. Median survival of melanoma-bearing mice was without 6-OHDA treatment 29 days and aft er 6-OHDA treatment 34 days. However, there was no diff erence in the incidence of melanoma in mice with intact sympathetic nerves (100% incidence of tumors -all animals injected with melanoma cells had developed tumor) and sympathectomized mice (two animals from all injected with melanoma cells did not develop tumor that represents 92.6% (Horvathova et al. 2016b ). Moreover, the eff ect of the chemical sympathectomy on the melanoma progression was assessed also by weighting of developed melanoma mass. In mice sacrifi ced in earlier stage of melanoma growth (on the 20 th day aft er B16-F10 melanoma cells injection), 6-OHDA treatment resulted in a signifi cant reduction of the tumor mass when compared to animals with the intact sympathetic nerves (Horvathova et al. 2016a) . Interestingly, in survival st udy we found that weight of the developed melanoma tissue in sympathectomized animals was signifi cantly increased in comparison with vehicle group animals (Horvathova et al. 2016b ).
In the contrary to the above-mentioned fi ndings, the chemical sympathectomy did not aff ect the incidence of the ascites hepatoma in Wistar rats. We found ascites in the abdominal cavity of 80.9% animals with an intact sympathetic nervous system and injected with tumor cells compared to 80% rats in the group that received 6-OHDA before injection of the tumor cells. Similarly, sympathectomy did not aff ect survival of tumor-bearing rats in comparison with the tumor-bearing animals with intact sympathetic nervous system. Median survival of tumorbearing rats with intact sympathetic nerves was 17 days and of the tumor-bearing animals underwent sympathectomy 18 days .
Subdiaphragmatic vagotomy.
Subdiaphragmatic vagotomy was performed 14 days before the tumor cells application to rats weighing 225±25 g. Prior to surgery, all the animals were food deprived overnight. Rats were anesthetized with an intramuscular injection of a mixture of ketamine (Narkamon 5% -1.2 ml/kg body weight, Spofa, Czech Republic) and xylazine (Rometar 2% -0.4 ml/kg body weight, Spofa, Czech Republic). Th e vagal trunks were isolated via upper midline laparotomy, following which the ventral and dorsal branches of the subdiaphragmatic vagus nerve were cut. In sham-operated rats, the vagal trunks were similarly exposed but the vagal branches were not cut. To avoid the gastrointestinal complications of vagotomy (e.g. gastrostasis), all the vagotomized and sham operated rats were fed with a liquid nutrition (Fresubin, Germany) for 7 days following surgery.
Th is surgical intervention, carried out in order to reduce signals conveyed by the vagus nerve, was performed only in rats that were subsequently injected with either fi brosarcoma or hepatoma cells.
Incidence of the rat intra-abdominal fi brosarcoma in Wistar rats was slightly reduced by subdiaphragmatic vagotomy in comparison with shamoperated animals. We found tumor masses in the abdominal cavity of 29.2% vagotomized rats. In contrast, we detected tumors in 45.8% sham-operated animals. However, we did not fi nd any significant diff erence in the survival of vagotomized rats (median survival 57 days) versus sham-operated rats (median survival 51 days) .
Subdiaphragmatic vagotomy aff ected neither incidence of the ascites hepatoma in Wistar rats nor survival of these animals. Th ere were no diff erences in the tumor incidence between the animals underwent vagotomy or sham operation. Th e presence of ascites was confi rmed by 83.3% in sham-operated rats in comparison with 58.3% animals with subdiaphragmatic vagotomy. No marked eff ect of subdiaphragmatic vagotomy was observed also in survival of the tumor-bearing rats. Median survival of shamoperated rats was 19 days and 19.5 days of animals underwent to vagotomy (unpublished data).
Electric stimulation of the vagus nerve (VNS). Implantation of stimulators was performed 14 days before tumor cells application in rats weighing 200-250 g. Rats were implanted with VNS or sham devices [VNS micropulse -model 103 by Cyberonics Inc. (USA) with the following dimensions: 7×42×32 mm, oval shape; weight 15.6 g] under anesthesia (an intramuscular injection of a mixture of ketamine and xylazine) and aseptic conditions. Th e body of the stimulator was implanted subcutaneously into the animal's back. Th e connecting cable with electrodes was lead under the skin with the active ends of electrodes placed around the left cervical portion of the vagus nerve. Sham animals underwent the same surgical procedure with implantation of connecting cable and electrodes, but with a sham device of the same size and weight used in place of the functional stimulator. Th e devices were set up using NeuroCybernetic Prosthesis hand-held computer and programming wand (Cyberonics Inc.) and the impedance of electrodes was measured to confi rm the presence of an appropriate contact between the nerve and the stimulating coil. Activation of functional VNS was performed three days aft er the tumor cells injection. Th e stimulators were turned on and programmed as following: 30 s on and 5 min off in continuous cycles, at a frequency of 20 Hz, pulse width of 500 μs, with an intensity of 0.25 mA.
Th is surgical intervention carried out in order to stimulate a cholinergic anti-infl ammatory pathway and to reduce cancer-related infl ammation was performed only in rats, which were subsequently injected with either fi brosarcoma or hepatoma cells.
Th e electric stimulation of the vagus nerve did not infl uence the incidence of the intra-abdominal fi brosarcoma in Wistar rats. Aft er 94 days of a continual vagal stimulation, tumors developed in 55% of animals from VNS group versus 80% of group of rats with sham devices. Survival of tumor-bearing animals was determined by the number of rats surviving up to 94 days aft er VNS activation. Similarly, vagal stimulation did not aff ect survival of rats injected with fi brosarcoma cells (median survival 42 days) in comparison to rats with sham devices (median survival 46 days) .
In the case of the ascites hepatoma, 29 days lasting continuous stimulation of the vagus nerve also did not aff ect the tumor incidence in Wistar rats. Th e presence of ascites was confi rmed in 60% of the experimental a nimals from VNS group. In the group of the tumor-bearing rats with sham devices, ascites was found in 71.4% animals. VNS had also no impact on the survival of the tumor-bearing animals. Median survival of rats w ith sham devices was 19 days and of animals from VNS group 20 days (unpublished data).
Discussion
A number of recently published studies have indicated that the nervous system may infl uence the progression of cancer by inhibiting the immune system functions, aff ecting the metabolic reprogramming of tumor cells, stimulating angiogenesis, or aff ecting the interactions between the tumor cells and other cellular and structural components of the tumor microenvironment (Shang 2007; Sloan et al. 2010; Park et al. 2011; Shi et al. 2013; Calvani et al. 2015; Chang et al. 2015) . Although, there are ambiguities especially about the role of the parasympathetic nerves in the growth of diff erent types of tumors, generally, it has been shown that autonomic neurotransmitters may stimulate the cancer cell growth through the activation of the cancer-related signaling pathways (Jobling et al. 2015) . Moreover, two signifi cant neurobiological studies in prostate and gastric cancer (Magnon et al. 2013; Zhao et al. 2014) have revealed that the sympathetic and parasympathetic nerves are signifi cantly involved in all phases of the prostate cancer development in the mouse and surgical or pharmacologic denervation of the mouse stomach strongly reduces tumor incidence and progression of the gastric cancer. Although, it is known that the sympathetic and parasympathetic nervous systems may aff ect the functions of the innervated tissues and organs in opposite way, the above-mentioned studies have suggested that in cancer they act complementary to each other; sympathetic nerves stimulate early phases of tumor growth and parasympathetic ones activate the late metastatic process (Jobling et al. 2015) . Using several experimental approaches (surgical as well as pharmacological), we have investigated the participation of sympathetic and parasympathetic nerves in cancer development and progression. Th e results obtained from our experimental studies have supported the stimulatory role of the sympathetic neurotransmission in the case of an intra-abdominal rat fi brosarcoma (Lackovicova et al. 2011 ) and subcutaneous murine melanoma (Horvathova et al. 2016b ). However, the involvement of the parasympathetic nerves in growth of rat intra-abdominal fi brosarcoma has not been observed . It is necessary to note that all the tumor models used for the investigation of the autonomic neurotransmission role in the processes related to the cancer growth and progression are solid, e.g. prostate cancer, gastric cancer, fi brosarcoma, melanoma, tongue cancer, or breast cancer (Raju et al. 2009; Lackovicova et al. 2011; Erin et al. 2012; Magnon et al. 2013; Zhao et al. 2014; Calvani et al. 2015; Mikova et al. 2015) . It may be assumed that just the solid nature of these tumors will make them the suitable substrate for the direct action of neurotransmitters released from the autonomic nerves. Mancino and colleagues (2011) have proposed that tumor development, like normal organ homeostasis, should be considered as a result of continuous bidirectional interactions between the tumor cells and their surrounding microenvironment. It is known that the angiogenesis, lymphangiogenesis, as well as neurogenesis are essential for tissue homeostasis in the healthy individuals (Mancino et al. 2011) .
Th e role of the blood and lymphatic vessels in the malignant progression of the cancer have been well described (Bergers and Benjamin 2003; Hillen and Griffi oen 2007; Sundar and Ganesan 2007) , but cancer-related formation of nerves or axons has not been supposed for a long time. However, recent evidence has led to the description of a novel biological phenomenon. It has been proved that the solid tumors, like another integrated tissues, are able to release neurotrophic factors that regulate the survival, growth, and diff erentiation of the nerve cells and so initiate their own innervation (Palm and Entschladen 2007; Olar et al. 2014) . Th is infi ltration of the tumor microenvironment by nerves has been termed as tumor neoneurogenesis or axonogenesis (Entschladen et al. 2006) . Th e experimental data have suggested that these nerves may play an active role in the cancer progression and enable the brain infl uence this process directly by nervous pathways (Shi et al. 2013 ). However, the detailed knowledge of the role of nerves in the tumors is obscure. Initially, it was thought that the role of the nerve fi bers in the tumors is only mechanical and existing nerves will serve as mechanical "paths" that allow the migration of the invading cells and contribute to the tumor progression (Liebig et al. 2009; Jobling et al. 2015) . Th is process has been called as a perineural invasion and has been correlated with a poorer prognosis in various human tumors (Anderson et al. 1998; Bauman and McVary 2013) . During perineural invasion, the tumor cells migrate along nerves, but nerves themselves are "passive" components in this process (Jobling et al. 2015) . However, accumulating evidence have suggested that the nerves found in tumors are not passive, but in fact they are functionally relevant, modulating a complex of mediators network related to the tumor microenvironment (Mancino et al. 2011) . It seems that nerve fi bers may infi ltrate into the tumor tissue stimulating the growth and dissemination of cancer cells and reciprocally, the tumor cells may drive the nerve outgrowth in a cross-talk that contributes to the tumor progression (Jobling et al. 2015) . In support of this, it is known that the neurotransmitters released form nerve endings may modulate the biological behaviors of both tumor and stromal cells by binding to the related receptors expressed by these cells (Entschladen et al. 2002; Moody et al. 2003; Soll et al. 2010; Mayordomo et al. 2012; Moreno-Smith et al. 2013) . Th erefore, local microenvironment and multiple physiologic processes of the tumor development may be controlled by nerves and the brain (Shi et al. 2013) .
To elucidate and extend the knowledge about the mechanisms responsible for modulatory eff ects of the autonomic nervous system on the development and progression of solid tumors further investigations are necessary. Importantly, there are no data related to the role of nervous system in non-solid tumors of ascitic type. Th erefore, we have started to investigate this. We have performed series of experiments in order to determine whether reduced or exaggerated autonomic neurotransmission has the same impact on the development and progression of malignant ascites as in the case of the solid tumors. However, we have found that the surgical and pharmacological experimental approaches used (chemical sympathectomy, subdiaphragmatic vagotomy, or electrical stimulation of the vagus nerve) had no eff ect on the development and progression of the ascites hepatoma or on the survival of asictes-bearing animals. We have supposed that the ascitic nature of this type of tumor does not allow forming blood and lymphatic vessels and nerves, which play a signifi cant role in the tumor progression.
Th e presence of malignant ascites is a common and distressing complication of the human abdominal cancer with abdominal distension and changes in abdominal girth as the classic symptoms (Stanojevic et al. 2004) . Usually, malignant ascites is a sign of the peritoneal carcinomatosis (malignancies including ovarian, colorectal, pancreatic and uterine; extraabdominal tumors originating from lymphoma, lung and breast; and a small number of unknown primary tumors) and indicates the presence of malignant cells in the peritoneal cavity. Importantly, it represents a signifi cant marker of a poor prognosis (Sangisetty and Miner 2012) .
Th e pathogenesis of the malignant ascites formation is a complex multifactorial process. It has been postulated that the major factors in the malignant ascites formation are the altered vascular permeability and the obstructed lymphatic drainage (HolmNielsen 1953; Sangisetty and Miner 2012) . It has been shown that vessels of the peritoneal lining in experimental animals with tumor ascites were signifi cantly more permeable, due to the presence of a permeability factor found only in the tumor ascites (Senger et al. 1983) . Particularly, the combination of an impaired lymphatic drainage and increased vascular permeability presents the mechanism responsible for the fl uid and protein accumulation in the intraperitoneal space. Th ese processes are intertwined, allowing for the net fi ltration that overwhelms the ability of the lymphatic system to drain the peritoneal space, particularly when obstructed by increasing tumor burden (Sangisetty and Miner 2012) . Th e quality of the fl uid in patients with malignancy related ascites is, due to peritoneal carcinomatosis, distinctive with positive cytology of malignant cells, large number of white blood cells, higher lactate dehydrogenase level, high ascitic fl uid protein concentrations (it indicates an alteration in vascular permeability that allows accumulation of large molecules in the intraperitoneal space), and low serum-ascites albumin gradient (Runyon et al. 1988; Bjelakovic et al. 2001; Sangisetty and Miner 2012) . Hence, the ascitic fl uid may be used for various biochemical, cytological, and microbiological analysis that can help in the diff erential diagnosis of ascites (Stanojevic et al. 2004) .
Th e use especially of the mouse ascites tumors, as an experimental tool in cancer research, is wellestablished (Siegler and Koprowska 1962) . In our animal experiments, the rat Yoshida AH-130 ascites hepatoma was used for study of interactions between the nervous system and cancer. Th is type of ascites was originally prepared by conversion of the aminoazo-dye-induced hepatoma of the rat into the ascitic form and it is similar in all aspects to other types of ascites tumors of various derivations (Yoshida 1956 ). It has widely been used in experimental studies investigating the cancer anorexia-cachexia syndrome, since in the host the implantation of these tumor cells leads to a very fast and progressive body weight loss associated with both fat and skeletal muscle wasting, reduced food intake accompanied by anorexia in the terminal state, and protein and lipid hypercatabolism (Tessitore et al. 1987; Costelli et al. 1999) . It is a highly cachectic rat tumor of rapid growth and poorly diff erentiated cells (Marzabal et al. 1993) . It is necessary to note that the animals inoculated with the ascites hepatoma present beside accumulation of the ascitic fl uid ample solid tumors on the peritoneal surface, which may invade into the surrounding tissues, and are identifi ed easily as hepatoma on histological sections (Yoshida 1956 ). Distant metastases of the tumor can occur rarely due to the relatively short duration of the tumor-bearing animals' life (Yoshida 1956 ). In our experiments, we have never found any metastases formation.
We have proposed that one of the signifi cant pathways that may enable interactions between the nervous system and tumor in form of ascites is neural regulation of the immune system that has the capacity to recognize tumor-associated antigens and develop antigen-specifi c humoral and cell mediated responses to these targets (Giuntoli et al. 2009 ). It is now well established that nervous and immune systems exhibit intricate bi-directional interactions to facilitate the fi ne control required maintaining homeostasis of the body (Karimi et al. 2010) . Neuroanatomical and neuroendocrine studies have demonstrated a role for the nervous system in regulating immune function via the hypothalamic-pituitary-adrenal axis and the autonomic nervous system (Meltzer et al. 1997) . Traditionally, investigations are focused on the sympathetic control of the immune response. Th e sympathetic arm of the autonomic nervous system may play the major role in the immune function regulation via the direct sympathetic innervation of all immune organs (Nance and Sanders 2007) . However, a number of more recent studies have highlighted the role of the eff erent parasympathetic system and in particular a role for the vagus nerve in immunoregulation through cholinergic signaling at the α7 subtype of nicotinic receptor, even if there are several open questions regarding the mechanisms (Borovikova et al. 2000; Tracey 2002; Gidron et al. 2005; Pavlov and Tracey 2005; Wang et al. 2007 ). In our experiments, manipulation with sympathetic or parasympathetic nerves does not aff ect the ascites hepatoma development and progression in Wistar rats. However, reduced sympathetic neurotransmission led to an increased prognostic marker of infl ammation, neutrophil-to-lymphocyte and leukocyteto-lymphocyte ratios, and increased plasma levels of proinfl ammatory cytokine tumor necrosis factor alpha in tumor-bearing rats . Th erefore, it appears that by aff ecting the autonomic nerves, functional alterations in the immune system components may occur, but in the case of the ascites tumor, these had no signifi cant eff ect on the cancer progression. Th erefore, on the base of abovementioned fi ndings, it seems that the direct communication between tumor cells and nerves is necessary for the eff ective modulatory eff ects of nervous system on the cancer progression.
Conclusion
In summary, our data indicate that based on the tumor type, signifi cant diff erences in the eff ect of the nervous system on the tumor growth and development of metastases, may exist. Especially, the sympathetic nerves may markedly aff ect the progression of diff erent solid tumors, regardless of the site of their growth (intraperitoneal vs. subcutaneous). However, the observed paradigm was not showed in the case of the ascites hepatoma. It seems that crucial role in these diff erences may play the solid tumors by the direct sympathetic innervations supply, whereas released neurotransmitters may modulate the behavior of the tumor and other stromal cells by paracrine manner. On the other hand, we did not reveal significant role of the parasympathetic nerves in the tumor progression regardless of the place its growth.
